About Siloton

Siloton develops miniaturised optical technology for medical imaging, compressing hospital-grade eye scanners into photonic chips smaller than a coin. The company specialises in Optical Coherence Tomography (OCT) systems that detect and monitor major eye diseases including macular degeneration, glaucoma, and diabetic retinopathy. The technology enables mass-manufacturable, portable devices at traditional cost fractions. This breakthrough moves eye health monitoring beyond hospitals into clinics, communities, and homes. By making advanced retinal imaging accessible wherever patients are, Siloton addresses clinical bottlenecks and reduces sight loss. The technology also detects early signs of multiple sclerosis, diabetes, and cancers.